Company Filing History:
2 out of 1,196 
1 out of 2,202 
Years Active: 1995-2003
Title: Innovations of Ross C Beier
Introduction
Ross C Beier is an accomplished inventor based in College Station, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of three patents to his name, Beier's work has had a notable impact on drug detection and analysis.
Latest Patents
Beier's latest patents include innovative methods for detecting specific drugs using monoclonal antibodies. One of his patents focuses on monoclonal antibodies to the drug tilmicosin. Hybridoma cell lines have been generated that produce and secrete antibodies which selectively bind to tilmicosin. These hybridomas can be obtained using 23-deoxo-23-demycinosyl tilmicosin conjugated to an immunogenic carrier. The antibodies developed can be used to detect and quantify tilmicosin in biological samples and may also be incorporated into detection kits.
Another significant patent involves monoclonal antibodies to 4,4′-dinitrocarbanilide (DNC), the active agent of nicarbazin. Hybridoma cell lines have been created that produce antibodies selectively binding to DNC. These hybridomas can be generated using p-nitroaniline conjugated to an immunogenic carrier. The antibodies allow for the detection and quantification of DNC in biological samples, forming an immunocomplex that can be detected when DNC is present. Similar to his other patent, these antibodies can also be incorporated into kits for the detection and quantification of DNC and nicarbazin.
Career Highlights
Throughout his career, Beier has worked with various organizations, including the United States of America, as represented by the Secretary of Agriculture. His work has been instrumental in advancing the field of drug detection and analysis through innovative methodologies.
Collaborations
Beier has collaborated with notable individuals in his field, including Larry H Stanker and Colin R Young. These collaborations have contributed to the success of his research and the development of his patents.
Conclusion
Ross C Beier is a prominent inventor whose work in monoclonal antibodies has paved the way for advancements in drug detection. His innovative patents reflect his dedication to improving methodologies in biotechnology.